Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_assertion type Assertion NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_head.
- NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_assertion wasGeneratedBy ECO_0000203 NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_provenance.
- NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_assertion wasDerivedFrom befree-20140225 NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_provenance.
- NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_assertion SIO_000772 18942640 NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_provenance.
- NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_assertion evidence source_evidence_literature NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_provenance.
- NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_assertion description "[The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP700186.RAln_mQi2dXQsgwb2MAFmjedRPra8ytsNMZErwZNPbApg130_provenance.